Table 1 Analysis of NHL cell lines for... | American Society of Hematology

Table 1

Analysis of NHL cell lines for sensitivity to rhApo2L/TRAIL alone and in combination with rituximab

Cell lines	NHL type	IC_{50, ng/mL}
Cell lines	NHL type	rhApo2L/TRAIL	rhApo2L/TRAIL + rituximab
BJAB	BL	32	26
Ramos RA1	BL	38	17
DoHH-2	FL	14	—*
SC-1	FL	> 1000	> 1000
Ramos T1	BL	33	13
Raji	BL	> 1000	> 1000
Daudi	BL	> 1000	> 1000
OCI-Ly19	DLBCL	> 1000	> 1000

Cell lines	NHL type	IC_{50, ng/mL}
Cell lines	NHL type	rhApo2L/TRAIL	rhApo2L/TRAIL + rituximab
BJAB	BL	32	26
Ramos RA1	BL	38	17
DoHH-2	FL	14	—*
SC-1	FL	> 1000	> 1000
Ramos T1	BL	33	13
Raji	BL	> 1000	> 1000
Daudi	BL	> 1000	> 1000
OCI-Ly19	DLBCL	> 1000	> 1000

BL indicates Burkitt lymphoma.

Rituximab (1000 ng/mL) has single-agent activity, which precludes comparing the IC₅₀ values of the cell viability curves for this cell line.